|
Chesapeake Biological bays about pharmaceutical prospects. Chesapeake Biological Laboratories (CBL) provides product development and commercial drug production services for pharmaceutical and biotechnology companies. It also manufactures experimental drugs for use in clinical trials. The company specializes in biopharmaceuticals, materials derived from naturally occurring biological substances. CBL's primary operations are sterilizing and filling liquid drugs and production lyophilization, the process of filling drug containers while limiting the product's exposure to room temperature. CBL is a wholly-owned subsidiary of Canadian biopharma firm Cangene.
|
| | | Contact Information | |
Address: |
1111 S. Paca St.
Baltimore, MD 21230-2591
| | Phone: | 410-843-5000 | | Fax: | 410-843-4414 |
|
|
Key People
| | • |
VP, Operations, Cangene:
William Labossiere (Bill) Bees
| | • |
VP, Operations:
Vicki Wolff-Long
| | • |
VP, Business Development and Marketing:
Steven E. Rowan
|
|
|
